Cardiovascular Effects of Angiotensin-(1-7) in Obesity Hypertension — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Cardiovascular Effects of Angiotensin-(1-7) in Obesity Hypertension — Stella

Recruiting

Back to Obesity trials

Early Phase 1 — Very small initial tests in humans, typically just a few people, to make sure the treatment is safe enough to study further.

Trial locations(1 site)

United States

Penn State Milton S. Hershey Medical Center, Hershey, Pennsylvania

Key details

Phase

Very early testing

Sponsor

Milton S. Hershey Medical Center

Collaborators

National Heart, Lung, and Blood Institute (NHLBI)

Enrollment target

~52 participants

Started

January 2025

Primary completion

March 2029

Age range

18 Years – 65 Years

Last updated September 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov